Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.45 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | MGAM | O43451 | 1/20 | 0.43 |
| ▸ | SI | P14410 | 1/20 | 0.43 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.36 |
| ▸ | F2 | P00734 | 2/20 | 0.36 |
| ▸ | KLK1 | P06870 | 2/20 | 0.36 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5476790 | 0.98 | CA12 (0.47) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL3762225 | 0.96 | CA12 (0.48) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL8572647 | 0.92 | CA12 (0.46) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL11731007 | 0.85 | CYP1A2 (0.43) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL11701536 | 0.84 | CA12 (0.48) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL28761333 | 0.82 | TSHR (0.50) | ALDH1A1HCAR2KDM4EHPGDKMT2A | |
| SCHEMBL3999882 | 0.82 | TSHR (0.43) | ALDH1A1GAASMN1; SMN2KDM4EMEN1 | |
| SCHEMBL1557949 | 0.81 | CA12 (0.42) | CA12CA1CA2CA9ALDH1A1 | |
| Hydrochloric Acid SCHEMBL28928298 | 0.80 | TSHR (0.49) | ALDH1A1HCAR2KDM4EHPGDKMT2A | |
| SCHEMBL65107 | 0.80 | CA12 (0.61) | CA12CA1CA2CA9ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230340011-A1 | STEROIDAL COMPOSITIONS AND METHODS OF TREATING LIPOGENIC CANCERS | Asteroid Therapeutics | 2023-10-26 | — | — | US | disclosed |
| US-20230340011-A1 | STEROIDAL COMPOSITIONS AND METHODS OF TREATING LIPOGENIC CANCERS | Asteroid Therapeutics | 2023-10-26 | — | — | US | disclosed |
| WO-2023205801-A2 | STEROIDAL COMPOSITIONS AND METHODS OF TREATING LIPOGENIC CANCERS | Asteroid Therapeutics (US) | 2023-10-26 | — | — | WO | disclosed |
| US-9481590-B2 | Poly(zwitterion-alt-sulfur dioxide) copolymer | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2016-11-01 | — | — | US | disclosed |
| US-9481590-B2 | Poly(zwitterion-alt-sulfur dioxide) copolymer | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2016-11-01 | — | — | US | disclosed |
| US-9359458-B2 | Polyzwitterionic acid antiscalant compound | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2016-06-07 | — | — | US | disclosed |
| US-20150183903-A1 | POLYZWITTERIONIC ACID ANTISCALANT COMPOUND | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2015-07-02 | — | — | US | disclosed |
| US-20150144569-A1 | POLY(ZWITTERION-ALT-SULFUR DIOXIDE) COPOLYMER | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2015-05-28 | — | — | US | disclosed |
| US-20150144569-A1 | POLY(ZWITTERION-ALT-SULFUR DIOXIDE) COPOLYMER | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2015-05-28 | — | — | US | disclosed |
| US-8937104-B2 | Cross-linked polyzwitterion/anion for the removal of strontium from aqueous solutions | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2015-01-20 | — | — | US | disclosed |
| US-8895633-B2 | Cross-linked polyaminocarboxylates for the removal of metal ions from aqueous solutions | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2014-11-25 | — | — | US | disclosed |
| US-8895633-B2 | Cross-linked polyaminocarboxylates for the removal of metal ions from aqueous solutions | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2014-11-25 | — | — | US | disclosed |
| US-20140323685-A1 | CROSS-LINKED POLYZWITTERION/ANION FOR THE REMOVAL OF STRONTIUM FROM AQUEOUS SOLUTIONS | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2014-10-30 | — | — | US | disclosed |
| US-20140249284-A1 | CROSS-LINKED POLYAMINOCARBOXYLATES FOR THE REMOVAL OF METAL IONS FROM AQUEOUS SOLUTIONS | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2014-09-04 | — | — | US | disclosed |
| US-20140249284-A1 | CROSS-LINKED POLYAMINOCARBOXYLATES FOR THE REMOVAL OF METAL IONS FROM AQUEOUS SOLUTIONS | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2014-09-04 | — | — | US | disclosed |
| WO-2009100996-A2 | PROCESS FOR PREPARING PYRAZOLE FUNCTIONALIZED BENZODIAZEPINONES | F. HOFFMANN-LA ROCHE AG (CH) | 2009-08-20 | — | — | WO | disclosed |
| US-20090203901-A1 | Process for preparing pyrazole functionalized benzodiazepinones | ROCHE COLORADO CORPORATION | 2009-08-13 | — | — | US | disclosed |
| US-20070004889-A1 | Polymers based on n,n-diallylamine derivatives their production and use | BASF AKTIENGESELLSCHAFT (DE) | 2007-01-04 | — | — | US | disclosed |
| EP-1670837-A1 | POLYMERS BASED ON N,N-DIALLYLAMINE DERIVATIVES, THEIR PRODUCTION AND USE | BASF AKTIENGESELLSCHAFT (DE) | 2006-06-21 | — | — | EP | disclosed |
| WO-2005037882-A1 | POLYMERS BASED ON N,N-DIALLYLAMINE DERIVATIVES, THEIR PRODUCTION AND USE | BASF AKTIENGESELLSCHAFT (DE) | 2005-04-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230340011-A1 | STEROIDAL COMPOSITIONS AND METHODS OF TREATING LIPOGENIC CANCERS | SREBF1, SREBF2, NR1H3 | CA12 4344/4885CA1 4426/4885CA2 4355/4885 |
| US-20090203901-A1 | Process for preparing pyrazole functionalized benzodiazepinones | AANAT, MAOB, ADRA1B | CA12 4796/4885CA1 4134/4885CA2 4601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.